Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight loss

BACKGROUND: Evidence suggests that endocannabinoid system activation through the cannabinoid receptor 1 (CB1) is associated with enhanced liver injury, and CB1 antagonism may be beneficial. The aim of this study was to determine the impact of rimonabant (CB1 antagonist) on alanine aminotransferase (...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Endocr Disord
Autors principals: Dawson, Alison J., Kilpatrick, Eric S., Coady, Anne-Marie, Elshewehy, Abeer M. M., Dakroury, Youssra, Ahmed, Lina, Atkin, Stephen L., Sathyapalan, Thozhukat
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5512818/
https://ncbi.nlm.nih.gov/pubmed/28705172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-017-0194-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars